TipHub

326

+4.25 +1.32%

29 Jul 2026

NSE Listed · Healthcare

Bajaj HealthCare Limited (BAJAJHCARE)

Volume: 1,70,729Avg Vol 1W: 3,79,685Avg Vol 1M: 5,07,08652W Range:272.35537.95
Market Cap
Current Price₹326
Previous Close₹321.75
High / Low (52w)₹537.95 / ₹272.35
Volume1,70,729
Avg Vol (1W)3,79,685
Avg Vol (1M)5,07,086
Stock P/E53.69
Book Value₹158.35
Dividend Yield
ROE
ROA
Revenue (TTM)₹611 Cr
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value₹5
EPS (TTM)₹-7.16
P/B2.06
Debt / Equity
50 DMA₹321.55
200 DMA₹362.2
Day change+1.32%
Price Chart
326 36.78% · 1Y
5502751.5Cr
2025-07-29
2026-07-29

20-day avg volume: 4.5L shares

Pros
  • Revenue grew 17% YoY.
Cons
  • Stock trades at a high P/E of 54.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹133 Cr₹123 Cr₹154 Cr₹149 Cr₹148 Cr₹161 Cr₹153 Cr₹166 Cr
EBITDA₹20 Cr₹17 Cr₹18 Cr₹20 Cr₹22 Cr₹25 Cr₹18 Cr₹23 Cr
Net Profit₹9 Cr₹12 Cr₹11 Cr₹12 Cr₹11 Cr₹16 Cr₹-23 Cr₹14 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹329 Cr₹371 Cr₹417 Cr₹664 Cr₹681 Cr₹647 Cr₹482 Cr₹562 Cr
EBITDA₹30 Cr₹32 Cr₹43 Cr₹127 Cr₹102 Cr₹96 Cr₹57 Cr₹74 Cr
Net Profit₹15 Cr₹16 Cr₹25 Cr₹83 Cr₹71 Cr₹43 Cr₹-84 Cr₹39 Cr
EPS22.0111.8218.2930.1125.8715.59-30.3613.12
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹283 Cr₹343 Cr₹526 Cr₹721 Cr₹898 Cr₹765 Cr₹833 Cr₹923 Cr
Total Liabilities₹130 Cr₹165 Cr₹267 Cr₹393 Cr₹530 Cr₹487 Cr₹367 Cr₹390 Cr
Equity₹153 Cr₹178 Cr₹258 Cr₹328 Cr₹368 Cr₹278 Cr₹466 Cr₹533 Cr
Total Debt₹249 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹79 Cr₹10 Cr₹-11 Cr₹105 Cr₹26 Cr₹58 Cr
Investing₹-109 Cr₹-75 Cr₹-93 Cr₹-11 Cr₹-15 Cr₹-48 Cr
Financing₹75 Cr₹62 Cr₹131 Cr₹-97 Cr₹-6 Cr₹24 Cr
Free Cash Flow₹79 Cr₹10 Cr₹-11 Cr₹105 Cr₹26 Cr₹15 Cr
Shareholding
Promoter 58.59% Institutions 4.11% Public 37.3%
About Bajaj HealthCare Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, phlebotropic drug, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

www.bajajhealth.com
Efficiency & Working Capital
ROCE10.3%
Interest Coverage2.5
Dividend Payout
Debtor Days169 d
Inventory Days109 d
Payable Days64 d
Cash Conversion Cycle214 d
Working Capital Days278 d
Shareholding Details

As of 2026-06-30

Promoter58.6%
FII2.2%
DII1.9%
Institutions4.1%
Public37.3%
Promoter Pledge0%
No. of Shareholders41,310
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters67.7%67.7%67.7%67.7%59.2%59.2%59.2%59.2%59.2%59.2%58.3%58.6%
FIIs0.7%0.7%0.5%0%1.1%1%1%1.1%1.1%1.2%2%2.2%
DIIs0.4%0%0.4%0%2%2.4%2.5%3.2%3%3%2.9%1.9%
Public31.2%31.5%31.3%32.3%37.8%37.4%37.2%36.6%36.7%36.7%36.8%37.3%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders28,00829,62632,71232,39731,99332,67235,71035,98038,57437,95138,15841,310
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Sajankumar Rameshwarlal BajajShareholding of Promoter and Promoter Group36.6%1.23 Cr
Anil Champalal JainShareholding of Promoter and Promoter Group6.1%20,36,544
Namrata BajajShareholding of Promoter and Promoter Group4.9%16,32,207
Nihita Bajaj KumarShareholding of Promoter and Promoter Group4.8%16,20,360
Babita Sajankumar BajajShareholding of Promoter and Promoter Group4.5%15,04,000
Deepak Ramanlal JoshiPublic Shareholding2.3%7,82,574
Hdfc Mutual Fund - Hdfc Pharma And Healthcare FundPublic Shareholding1.7%5,68,918
Padma Anil JainShareholding of Promoter and Promoter Group0.9%3,04,000
Bajaj Health And Nutritions LlpShareholding of Promoter and Promoter Group0.7%2,40,000
Bansal Pharma LimitedShareholding of Promoter and Promoter Group0.2%60,000
Skr Bajaj HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sanjankumar R BajajChairman / Executive Director / Managing Director2025
Namrata S BajajE D & Wholetime Director2025
Anil C JainManaging Director2025
Pakshal JainE D & Wholetime Director2025
Hemant R KarnikIndependent Non Exe. Director2025
Ram B BanaraseIndependent Non Exe. Director2025
Kejal ShahIndependent Non Exe. Director2025
GOPALAKRISHNAN KESAVANIndependent Non Exe. Director2025
Monica TanwarCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Bulk Drugs₹591 Cr86.9%
Formulation & Sale of Medicines₹89 Cr13.1%
Others₹0 Cr0%
Segments — Geography
RegionRevenueShare
India₹418 Cr77.1%
Outside India₹124 Cr22.9%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹5251616
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-20Board Meetings
dividend2025-09-19₹1 (20%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500021022
202500013014
2025000809
Insider / Designated-Person Trades

6 recent disclosure(s)

ANIL CHAMPALAL JAINAcquisition · 1,00,000
SAJANKUMAR RAMESHWARLAL BAJAJAcquisition · 4,55,074
ANIL CHAMPALAL JAINAcquisition · 4,55,074
ANIL CHAMPALAL JAINAcquisition · 7,095
ANIL CHAMPALAL JAINAcquisition · 7,600
ANIL CHAMPALAL JAINAcquisition · 3,000
Substantial Acquisitions (SAST)

5 disclosure(s)

Market12/06/2026 · 1,00,000
Conv. of Warrants18/03/2026 · 4,55,074
Allotment18/03/2026 · 4,55,074
Market17/03/2026 · 7,095
Market10/12/2025 · 2,000
Company Information
Incorporated1993
ChairmanSanjankumar R Bajaj
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]
🌐 www.bajajhealth.com

📍 602-606 Bhoomi Velocity Infote, Road No 23 Wagle Indl Estate, Thane, Maharashtra, 400604

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search